The global myocarditis treatment market is poised for steady expansion over the next decade, driven by rising awareness of cardiovascular diseases, advancements in diagnostic capabilities, and increasing investments in targeted therapies. Valued at approximately US$ 1.5 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2034, reaching...